{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T20:21:09Z","timestamp":1706646069758},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":1057,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1999,2]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Whether patients, who have lost bone mass, can be restored to age\u2010matched control levels by some means is still controversial. We investigated how the thyroid status after antithyroid drug therapy for various periods of time affects bone metabolism in patients with hyperthyroidism by assessing currently used biochemical markers of bone turnover and distal radius bone mineral density (BMD).<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN AND PATIENTS<\/jats:title><jats:p>The biochemical markers of bone turnover and BMD at the distal one third of the radius were measured in 79 women with hyperthy\u2010roidism treated with antithyroid drugs for various periods of time. The patients were divided into two groups according to thyroid function at the time of study: a hyperthyroid group (serum thyroid stimulating hormone (TSH)\u2003&lt;\u20030.4\u2003mU\/l) and an euthyroid group (TSH\u20030.4\u20134.0\u2003mU\/l). Second, each group was further divided according to the duration of therapy: short\u2010term (less than 3 years ) and long\u2010term (3 or more years).<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS<\/jats:title><jats:p>Urinary type I collagen degradation products (CTx) were measured by the CrossLapsTM ELISA kit. Urinary pyridinoline (Pyr) and deoxypyridinoline (Dpyr) were measured by high performance liquid chromatography (HPLC) after acid hydrolysis. Serum N\u2010mid osteocalcin (OC<jats:sub>N\u2010mid<\/jats:sub>) was measured by a recently developed enzyme\u2010linked immunosorbent assay. Serum alkaline phosphatase (ALP) was determined by routine laboratory methods. Bone mineral density (BMD) at the distal one third of the radius was measured using dual energy X\u2010ray absorptiometry (DEXA; DCS\u2010600EX, Aloka, Tokyo).<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>There were statistically significant positive correlations of FT3 and FT4 with the biochemical markers of bone turnover. There were significant negative correlations between the biochemical markers and BMD only in patients undergoing long\u2010term therapy. In a comparison between hyperthyroid and euthyroid groups based on duration of treatment (long\u2010term and short\u2010term), and in a comparison without regard for length of treatment (all patients), it was evident that ALP and CTx levels were significantly higher in the hyperthyroid than in the euthyroid groups. Significantly lower BMD Z\u2010scores in the hyperthyroid group compared to those in the euthyroid group were observed only in patients undergoing long\u2010term therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Urinary type I collagen degradation products were a sensitive marker for evaluating the bone turnover in patients with hyperthyroidism. Our data suggested that it might be important to control the levels of TSH within normal ranges during long\u2010term antithyroid drug therapy in order to prevent bone loss.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1999.00626.x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T10:34:32Z","timestamp":1027679672000},"page":"171-176","source":"Crossref","is-referenced-by-count":24,"title":["Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time"],"prefix":"10.1111","volume":"50","author":[{"given":"Michio","family":"Oikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Kushida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitsuhiro","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1390009"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/clinchem\/40.11.2022","article-title":"Immunoassay for quantifying type I collagen degradation products in urine evaluated","volume":"40","author":"Bonde M.","year":"1994","journal-title":"Clinical Chemistry"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1210\/endo.134.1.8275930","article-title":"Osteoclast mediate thyroid hormone stimulation of osteoclastic bone resorption","volume":"134","author":"Britto J.M.","year":"1994","journal-title":"Endocrinology"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-6009(08)80115-8"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1210\/jcem-72-6-1184","article-title":"A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma","volume":"72","author":"Diamond T.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(85)90218-2"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1003633"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.4.955"},{"key":"e_1_2_6_10_2","first-page":"161","article-title":"Bone mass, bone turnover, calcium homeostasis, and body composition in former hyperthyroid patients treated by combined medical therapy","volume":"6","author":"Langdahl B.L.","year":"1996","journal-title":"Thyroid"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-3-766"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00972.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.4.818"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1699-0463.1977.tb00411.x","article-title":"Morphometric and dynamic studies of bone changes in hyperthyroidism","volume":"85","author":"Melsen F.","year":"1977","journal-title":"Acta Pathologica Microbiologica Scandinavica Section A Pathology"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.7.1083"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30338-4"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(94)90885-0"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/07435809209111037","article-title":"Quantitative analyses of urinary pyridinoline and deoxypyridinoline excretion in patients with hyperthyroidism","volume":"18","author":"Ohishi T.","year":"1992","journal-title":"Endocrine Reseach"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(92)90519-D"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.6.1531"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/clinchem\/41.10.1439","article-title":"Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies","volume":"10","author":"Rosenquist C.","year":"1995","journal-title":"Clinical Chemistry"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02489945"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.145.5.883"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1999.00626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1999.00626.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1999.00626.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T19:52:52Z","timestamp":1704311572000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1999.00626.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["10.1046\/j.1365-2265.1999.00626.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1999.00626.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}